Lineage Cell Therapeutics Price Target Announced at $3.00/Share by D. Boral Capital

lineage cell therapeutics 價格目標爲$3.00/股，由D. Boral Capital宣佈

道瓊斯 · 11/18 23:22 · 評級/大行評級

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.